These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15933755)

  • 1. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs.
    Cheng C; Tsuneyama K; Kominami R; Shinohara H; Sakurai S; Yonekura H; Watanabe T; Takano Y; Yamamoto H; Yamamoto Y
    Mod Pathol; 2005 Oct; 18(10):1385-96. PubMed ID: 15933755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
    Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
    J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.
    Nozaki I; Watanabe T; Kawaguchi M; Akatsu H; Tsuneyama K; Yamamoto Y; Ohe K; Yonekura H; Yamada M; Yamamoto H
    Arch Histol Cytol; 2007 Dec; 70(5):279-90. PubMed ID: 18431028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
    Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
    Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
    Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
    Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
    Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
    Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis.
    Takahashi T; Katsuta S; Tamura Y; Nagase N; Suzuki K; Nomura M; Tomatsu S; Miyamoto K; Kobayashi S
    Mol Med; 2013 Jul; 19(1):183-94. PubMed ID: 23821362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipidemia.
    Turk Z; Ljubić S; Boras J
    Physiol Res; 2014; 63(2):199-205. PubMed ID: 24397807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis.
    Liu XY; Li HL; Su JB; Ding FH; Zhao JJ; Chai F; Li YX; Cui SC; Sun FY; Wu ZY; Xu P; Chen XH
    J Neurochem; 2015 Apr; 133(2):187-98. PubMed ID: 25689357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of the receptor for advanced glycation end products and its ligands.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Watanabe T; Yamamoto H
    J Pharmacol Sci; 2005 Mar; 97(3):305-11. PubMed ID: 15750291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of Endogenous Secretory Receptor for Advanced Glycation End-products in Brain Ischemia.
    Shimizu Y; Harashima A; Munesue S; Oishi M; Hattori T; Hori O; Kitao Y; Yamamoto H; Leerach N; Nakada M; Yamamoto Y; Hayashi Y
    Aging Dis; 2020 May; 11(3):547-558. PubMed ID: 32489701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Nakatani Y; Ohtoshi K; Hayaishi-Okano R; Kosugi K; Hori M; Yamasaki Y
    Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.